Coming this October: the ACZM Exam Prep Course!

The ACZM Exam Prep Course is typically held in conjunction with a conference each year, providing 1.5 days of learning and networking opportunities. This year the course has the same great opportunities but with a new and exciting virtual format over Zoom from October 3-4. The ACZM Education Committee has partnered with the North Carolina State University Office of Continuing Education to provide 1.5 days of content including introduction to the ACZM Exam format and structure, in depth literature reviews on a variety of topics, Q&A sessions with members of the Exam and Credentialing Committees and Mock Examination. Most exciting is that this year the course will provide 9 RACE CE credit hours. The course is open to all veterinarians whether interested in taking the ACZM Exam in the near (or far!) future or any veterinarian who would benefit from a detailed review of topics in Zoological Medicine. For more information, including a complete schedule and details on registration, please visit the ACZM website.

AAWV Survey on FDA Draft Guidance for Compounding Animal Drugs from Bulk Drug Substances

https://forms.gle/PjnDTJFhvUSLesDb8

PLEASE COMPLETE THIS SURVEY BY MONDAY, SEPTEMBER 7, 2020

The American Association of Wildlife Veterinarians (AAWV) is surveying wildlife veterinarians who order and administer drugs that are compounded from bulk drug substances to wildlife species. The intent of the survey is threefold: (1) to gather information about which bulk compounded drugs wildlife veterinarians use, the frequency and purpose behind their use, and the species to which they are administered; (2) to catalog where wildlife veterinarians order bulk compounded drugs from; and (3) to determine how draft FDA guidance may impact wildlife veterinarians’ reliance on bulk compounded drugs.

A bulk compounded drug is a pharmaceutical that is derived from bulk drug substances or raw active ingredients. It is not to be confused with standard drug compounding which involves the manipulation of an FDA-approved drug into a preferred form (e.g., creating an oral suspension from crushed tablets, diluting the concentration of an injectable solution, mixing two or more injectable solutions).

The FDA draft guidance, if finalized, would advise veterinarians on circumstances under which the FDA does not intend to take action for certain violations of the Federal Food, Drug, and Cosmetic Act (FD&C Act) when pharmacists and veterinarians compound or oversee the compounding of animal drugs from bulk drug substances. Circumstances in which the FDA will forego enforcement include the preparation, prescription, and administration of bulk compounded drugs for a specific individual or a group of non food-producing animals, for office stock for non food-producing animals if the drug is on the FDA’s list of approved drugs, and for food-producing animals if the drug is on the FDA’s list of approved drugs and only if used as an “antidote for treating toxicosis”.

Pharmacies and veterinarians may therefore be held liable when dealing with unapproved bulk compounded drugs for office stock for non food-producing animals, unapproved bulk compounded drugs for food-producing animals, and even approved bulk compounded drugs for food-producing animals if not used as an antidote against a toxin. With many wildlife species available for harvest and thereby considered food-producing animals, such guidance would dramatically limit the availability of bulk compounded drugs to wildlife veterinarians.

For more background information: https://www.fda.gov/animal-veterinary/cvm-updates/fda-releases-revised-draft-guidance-compounding-animal-drugs-bulk-drug-substances.

For the draft guidance document: https://www.fda.gov/media/132567/download.

House Natural Resources Committee Livestreamed Roundtables This Week!

The House Natural Resources Committee is hosting two livestreamed events this week:

  • On Monday, Rep. Jared Huffman (D-Calif.), chair of the Water, Oceans, and Wildlife Subcommittee, will lead a roundtable on how coronavirus has impacted fisheries around the country. Tune in to Coronavirus Impacts on American Fisheries and the Seafood Supply at 1PM EDT on Monday, May 18.
  • On Tuesday, Chair Raúl M. Grijalva (D-Ariz.) will lead a roundtable discussion on limiting the spread of wildlife-borne diseases to humans. Speakers will discuss how the House’s newly passed Heroes Act improves research and testing for diseases at risk of being passed to humans and how federal agencies can protect the public from animal-to-human disease transmission. Tune in to Crossing the Species Barrier: The Growing Threat of Wildlife Disease to Human Health and What We Can Do About It at 1PM EDT on Tuesday, May 19.

Click here for speaker information, as well as the Facebook and YouTube streaming links.

CDC Zoonoses & One Health Updates Calls… CE Available!

From the Centers for Disease Control and Prevention (CDC): 

Zoonoses & One Health Updates (ZOHU) Calls are one-hour monthly webinars that provide timely education on zoonotic and infectious diseases, One Health, antimicrobial resistance, food safety, vector-borne diseases, recent outbreaks, and related health threats at the animal-human-environment interface. Free Continuing Education (CE) credit is available for live calls and recordings.

The next call is scheduled for Wednesday, May 6, 2020 from 2-3pm (EDT). Click here for details on how to join the call.

 

 

Is COVID-19 changing the way you spend time outdoors? Does that increase the risk of exposure of you, your family, or dogs to ticks or tick-borne diseases?

You are invited by researchers at The University of Georgia, Hollins University, Duke University, Clemson University, and the University of Rhode Island to participate in a research study entitled “Investigating COVID-19 impacts on the epidemiology of tick-borne diseases in people and pets”.

The purpose of this study is to determine if COVID-19 restrictions on society have had an effect on the time that people or their pets spend outdoors and if this change is associated with an increased risk of exposure to ticks or tick-borne diseases.

Any person who is 18 or older and a resident of the United States or Canada is eligible to participate.

Your participation will involve filling out a short survey that should only take about 10-15 minutes of your time (or less if you do not have children and/or dogs).

Please click here to access the survey or paste this link in your browser –  https://ugeorgia.ca1.qualtrics.com/jfe/form/SV_8kctqb7neC2Pyvj

Also, please share this survey with anybody that you think would be willing to complete the survey.

We greatly appreciate your participation in this study. If you have any questions about this research project, please contact the study supervisor, Dr. Michael Yabsley, at myabsley@uga.edu.